ATHA
Price
$1.97
Change
+$0.10 (+5.35%)
Updated
Dec 8, 6:59 PM EST
102 days until earnings call
AVXL
Price
$7.96
Change
-$0.17 (-2.09%)
Updated
Dec 8, 6:59 PM EST
60 days until earnings call
Ad is loading...

Compare predictions ATHA vs AVXL

Header iconATHA vs AVXL Comparison
Open Charts ATHA vs AVXLBanner chart's image
Athira Pharma
Price$1.97
Change+$0.10 (+5.35%)
Volume$191.63K
CapitalizationN/A
Anavex Life Sciences
Price$7.96
Change-$0.17 (-2.09%)
Volume$405.2K
CapitalizationN/A
View a ticker or compare two or three
ATHA vs AVXL Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ATHA vs. AVXL commentary
Dec 11, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Buy and AVXL is a Buy.

COMPARISON
Comparison
Dec 11, 2023
Stock price -- (ATHA: $1.97 vs. AVXL: $7.96)
Brand notoriety: ATHA and AVXL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 141% vs. AVXL: 70%
Market capitalization -- ATHA: $58.22M vs. AVXL: $522.07M
ATHA [@Biotechnology] is valued at $58.22M. AVXL’s [@Biotechnology] market capitalization is $522.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileAVXL’s FA Score has 0 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • AVXL’s FA Score: 0 green, 5 red.
According to our system of comparison, AVXL is a better buy in the long-term than ATHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 5 TA indicator(s) are bullish while AVXL’s TA Score has 5 bullish TA indicator(s).

  • ATHA’s TA Score: 5 bullish, 4 bearish.
  • AVXL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ATHA and AVXL are a good buy in the short-term.

Price Growth

ATHA (@Biotechnology) experienced а +30.46% price change this week, while AVXL (@Biotechnology) price change was +5.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10161.68%. For the same industry, the average monthly price growth was +8.48%, and the average quarterly price growth was +27.10%.

Reported Earning Dates

ATHA is expected to report earnings on Mar 21, 2024.

AVXL is expected to report earnings on Feb 08, 2024.

Industries' Descriptions

@Biotechnology (+10161.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ATHA with price predictions.
OPEN
A.I.dvisor published
a Summary for AVXL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AVXL($522M) has a higher market cap than ATHA($58.2M). AVXL YTD gains are higher at: -14.039 vs. ATHA (-37.855). AVXL has higher annual earnings (EBITDA): -53.77M vs. ATHA (-117.03M). ATHA has more cash in the bank: 173M vs. AVXL (155M). AVXL has less debt than ATHA: AVXL (88.2K) vs ATHA (1.67M). ATHA (0) and AVXL (0) have equivalent revenues.
ATHAAVXLATHA / AVXL
Capitalization58.2M522M11%
EBITDA-117.03M-53.77M218%
Gain YTD-37.855-14.039270%
P/E RatioN/AN/A-
Revenue00-
Total Cash173M155M112%
Total Debt1.67M88.2K1,896%
FUNDAMENTALS RATINGS
AVXL: Fundamental Ratings
AVXL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHAAVXL
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 6 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 19 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASHTY256.717.27
+2.91%
Ashtead Group Plc
PACK4.720.11
+2.39%
Ranpak Holdings Corp
VDMCY5.16-0.06
-1.15%
Vodacom Group Ltd
LUGDF11.89-0.46
-3.72%
Lundin Gold
VYNE2.99-0.25
-7.72%
VYNE Therapeutics

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with CRSP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+5.35%
CRSP - ATHA
38%
Loosely correlated
-8.08%
AGIO - ATHA
36%
Loosely correlated
-4.71%
OCUL - ATHA
36%
Loosely correlated
-2.69%
NUVB - ATHA
36%
Loosely correlated
+3.10%
ALNY - ATHA
35%
Loosely correlated
-4.07%
More

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-2.09%
BEAM - AVXL
55%
Loosely correlated
-8.17%
NTLA - AVXL
55%
Loosely correlated
-2.55%
DNLI - AVXL
51%
Loosely correlated
-1.97%
EDIT - AVXL
49%
Loosely correlated
-3.58%
VCYT - AVXL
48%
Loosely correlated
+2.40%
More